We use principles of fundamental T cell biology and tools from synthetic biology to design next-generation cellular therapies to combat cancer. We build, develop, and translate innovative therapeutic strategies with the ultimate goal of bringing cures to patients.
We are part of the Translation Science and Therapeutics division (TST) and the Immunotherapy Integrated Research Center (IIRC) at the Fred Hutchinson Cancer Center.
Our research is supported by: